Cytologic Features of ALK-Positive Pulmonary Adenocarcinoma

Korean Journal of Pathology

Volumn 47, Issue 3, 2013, Pages 252-257

  Ha, Seung Yeon ^a   Ahn, Jungsuk ^a   Roh, Mee Sook ^b   Han, Joungho ^c   Lee, Jae Jun ^c   Lee, Boin ^c   Yim, Jun ^a  

^a Gachon University   (South Korea)

^b Dong A University College of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Adenocarcinoma; Anaplastic lymphoma kinase; Carcinoma; Cytology; Lung; Non small cell lung

Indexed keywords

EID: 84882570686     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2013.47.3.252     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.
2. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000: the global picture. Eur J Cancer 2001; 37 Suppl 8: S4-66.
3. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6: 244-85.
4. Gold KA, Wistuba II, Kim ES. New strategies in squamous cell carcinoma of the lung: identification of tumor drivers to personalize therapy. Clin Cancer Res 2012; 18: 3002-7.
5. Perez-Moreno P, Brambilla E, Thomas R, Soria JC. Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities. Clin Cancer Res 2012; 18: 2443-51.
6. Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008; 455: 1069-75.
7. Chirieac LR, Dacic S. Targeted therapies in lung cancer. Surg Pathol Clin 2010; 3: 71-82.
8. Paik JH, Choi CM, Kim H, et al. Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma. Lung Cancer 2012; 76: 403-9.
9. Inamura K, Takeuchi K, Togashi Y, et al. EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset. Mod Pathol 2009; 22: 508-15.
10. Inamura K, Takeuchi K, Togashi Y, et al. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers. J Thorac Oncol 2008; 3: 13-7.
11. Jokoji R, Yamasaki T, Minami S, et al. Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma. J Clin Pathol 2010; 63: 1066-70.
12. Rodig SJ, Mino-Kenudson M, Dacic S, et al. Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population. Clin Cancer Res 2009; 15: 5216-23.
13. Kawahara A, Akiba J, Abe H, et al. EML4-ALK-positive lung adenocarcinoma with signet-ring cells. Diagn Cytopathol 2012 Nov 16[Epub]. http://dx.doi.org/10.1002/dc.22936.
14. Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007; 448: 561-6.
15. Yoshida A, Tsuta K, Nakamura H, et al. Comprehensive histologic analysis of ALK-rearranged lung carcinomas. Am J Surg Pathol 2011; 35: 1226-34.
16. Song HJ, Jeong JY, Choi Y, Han J. Histologic features of ALK-expressing adenocarciomas of the lung. J Lung Cancer 2011; 10: 32-6.
17. Shiota M, Nakamura S, Ichinohasama R, et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood 1995; 86: 1954-60.
18. Nizzoli R, Tiseo M, Gelsomino F, et al. Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer. J Thorac Oncol 2011; 6: 489-93.
19. Chhieng DC. Fine-needle aspiration cytology of pulmonary mucinous cystadenocarcinoma. Diagn Cytopathol 2008; 36: 581-5.
20. Morency E, Rodriguez Urrego PA, Szporn AH, Beth Beasley M, Chen H. The "drunken honeycomb" feature of pulmonary mucinous adenocarcinoma: a diagnostic pitfall of bronchial brushing cytology. Diagn Cytopathol 2013; 41: 63-6.